| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2217/17460913.3.6.649 |
| P698 | PubMed publication ID | 19072182 |
| P50 | author | Nicola Petrosillo | Q56395236 |
| Elda Righi | Q79385925 | ||
| Matteo Bassetti | Q88607142 | ||
| Laura Ambra Nicolini | Q42817130 | ||
| P2093 | author name string | Silvano Esposito | |
| P2860 | cites work | Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. | Q51752779 |
| Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. | Q53250268 | ||
| Epidemiological typing and prevalence of integrons in multiresistant Acinetobacter strains. | Q53668776 | ||
| Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test. | Q53845615 | ||
| Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. | Q53851336 | ||
| Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. | Q53872643 | ||
| Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii | Q54775354 | ||
| Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain | Q57726411 | ||
| AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex | Q58089224 | ||
| Risk factors, clinical features and outcome ofAcinetobacter bacteremia in adults | Q59187134 | ||
| Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii | Q59245528 | ||
| Relevance of Digestive Tract Colonization in the Epidemiology of Nosocomial Infections Due to Multiresistant Acinetobacter baumannii | Q59245547 | ||
| Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis | Q24802737 | ||
| Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 | Q28205309 | ||
| Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa | Q28256421 | ||
| Tigecycline: what is it, and where should it be used? | Q28268828 | ||
| Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3 | Q28283863 | ||
| Multidrug-resistant Acinetobacter baumannii | Q28306885 | ||
| Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study | Q29616607 | ||
| The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data | Q30998307 | ||
| Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. | Q31977163 | ||
| Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam | Q32049790 | ||
| Acinetobacter bacteremia in Hong Kong: prospective study and review. | Q33535379 | ||
| Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital | Q33967629 | ||
| Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii | Q33993176 | ||
| Integration of foreign DNA during natural transformation of Acinetobacter sp. by homology-facilitated illegitimate recombination | Q34012308 | ||
| Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. | Q34128899 | ||
| Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii | Q34157184 | ||
| Overview of nosocomial infections caused by gram-negative bacilli | Q34444001 | ||
| Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center | Q34568784 | ||
| Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England | Q34571574 | ||
| Rapid development of Acinetobacter baumannii resistance to tigecycline | Q34581377 | ||
| The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa | Q34581987 | ||
| AcinetobacterOutbreaks, 1977–2000 | Q35119005 | ||
| Treatment of Acinetobacter spp infections | Q35183740 | ||
| Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. | Q35690304 | ||
| Antimicrobial resistance of Acinetobacter spp. in Europe | Q35859069 | ||
| Multidrug-resistant Acinetobacter extremity infections in soldiers | Q35873386 | ||
| An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment | Q35991070 | ||
| Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections | Q36095874 | ||
| Tigecycline: a new glycylcycline for treatment of serious infections | Q36218312 | ||
| The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! | Q36242554 | ||
| Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals | Q36295402 | ||
| OXA (beta)-lactamases in Acinetobacter: the story so far. | Q36333095 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia | Q36559388 | ||
| Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance | Q36598039 | ||
| Outcomes of Acinetobacter baumannii infection in critically ill burned patients. | Q36757236 | ||
| Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California | Q36845404 | ||
| Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate | Q36998159 | ||
| The current state of multidrug-resistant gram-negative bacilli in North America | Q37069191 | ||
| Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. | Q37119524 | ||
| Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence | Q37147563 | ||
| Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options | Q37150308 | ||
| Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes | Q38461269 | ||
| Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit | Q38474747 | ||
| Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand | Q39145057 | ||
| Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii | Q39476331 | ||
| Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays | Q39657816 | ||
| Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. | Q39731888 | ||
| Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit | Q39816792 | ||
| Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem | Q40290852 | ||
| Activities of doripenem (S-4661) against drug-resistant clinical pathogens | Q41269719 | ||
| AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii | Q41859877 | ||
| Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel | Q41891521 | ||
| High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. | Q42165253 | ||
| Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii | Q42747669 | ||
| Transposon-mediated multiple antibiotic resistance in Acinetobacter strains | Q42926845 | ||
| Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq | Q43252602 | ||
| Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance | Q43452961 | ||
| Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: risk factors and attributable mortality. | Q43459734 | ||
| Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii | Q43705318 | ||
| Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). | Q43895580 | ||
| Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. | Q43961916 | ||
| Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes | Q43988737 | ||
| Multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit | Q44032743 | ||
| Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study | Q44043080 | ||
| Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned | Q44045605 | ||
| Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. | Q44123853 | ||
| Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam | Q44266822 | ||
| An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients' mattresses | Q44313795 | ||
| Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. | Q44417867 | ||
| Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. | Q44454728 | ||
| Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study | Q44609136 | ||
| In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain | Q44732953 | ||
| Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam | Q44832112 | ||
| Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. | Q45152687 | ||
| A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. | Q45182367 | ||
| Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains | Q45222964 | ||
| Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia | Q46335722 | ||
| Amikacin and colistin for treatment of Acinetobacter baumannii meningitis | Q46507457 | ||
| In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. | Q46528095 | ||
| Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. | Q46552025 | ||
| Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia | Q46577225 | ||
| Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. | Q46597761 | ||
| The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam | Q46634329 | ||
| In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii. | Q46634716 | ||
| How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. | Q46688031 | ||
| Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. | Q46749221 | ||
| An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil | Q46790780 | ||
| Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections | Q46824068 | ||
| Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit | Q46907740 | ||
| Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study | Q46929397 | ||
| Exceptional desiccation tolerance of Acinetobacter radioresistens | Q48768327 | ||
| The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents | Q48791203 | ||
| Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. | Q51379524 | ||
| P433 | issue | 6 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| Acinetobacter baumannii | Q3241189 | ||
| P1104 | number of pages | 12 | |
| P304 | page(s) | 649-660 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Future Microbiology | Q15759961 |
| P1476 | title | Drug treatment for multidrug-resistant Acinetobacter baumannii infections | |
| P478 | volume | 3 |
| Q37127944 | A 4-year surveillance of antimicrobial resistance patterns of Acinetobacter baumanni in a university-affiliated hospital in China |
| Q39865670 | Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran. |
| Q40229350 | Cloning, Expression, and Purification of Nucleoside Diphosphate Kinase from Acinetobacter baumannii |
| Q33676198 | Detection of KPC in Acinetobacter spp. in Puerto Rico |
| Q56385526 | Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a Teaching Hospital in China |
| Q96133907 | Development of multiplex PCR for rapid detection of metallo-β-lactamase genes in clinical isolates of Acinetobacter baumannii |
| Q49706174 | Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study |
| Q57167678 | First report of colistin resistance among carbapenem-resistant isolates recovered from hospitalized patients in Egypt |
| Q37263500 | Homeostasis of glutathione is associated with polyamine-mediated β-lactam susceptibility in Acinetobacter baumannii ATCC 19606 |
| Q35884503 | Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns |
| Q48051031 | Molecular modeling studies to explore the binding affinity of virtually screened inhibitor toward different aminoglycoside kinases from diverse MDR strains. |
| Q34300419 | Multidrug-resistant Acinetobacter baumannii infection in children |
| Q38383811 | National Survey of Thai Infectious Disease Physicians on Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: The Role of Infection Control Awareness |
| Q28293095 | Necrotizing fasciitis caused by Acinetobacter baumannii : A case report |
| Q54250219 | Optimizing Amikacin Dosage in Pediatrics Based on Population Pharmacokinetic/Pharmacodynamic Modeling. |
| Q40494723 | Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections |
| Q35548903 | Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model |
| Q47785464 | Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates |
| Q27675313 | Structure determination of LpxA from the lipopolysaccharide-synthesis pathway ofAcinetobacter baumannii |
| Q27675777 | Structure determination of LpxD from the lipopolysaccharide-synthesis pathway ofAcinetobacter baumannii |
| Q41891252 | Studies on New Delhi Metallo-Beta-Lactamse-1 producing Acinetobacter baumannii isolated from donor swab in a tertiary eye care centre, India and structural analysis of its antibiotic binding interactions |
| Q90710635 | Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem |
| Q28547854 | Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii |
| Q37643714 | Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. |
| Q40965515 | Task force on management and prevention of Acinetobacter baumannii infections in the ICU. |
| Q37588522 | The Impact of Antibiotic Consumption on Development of Acinetobacter Baumannii Resistance |
| Q92494772 | The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence |
| Q33503390 | The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey |
| Q33754166 | Therapeutic drug monitoring of amikacin in septic patients. |
| Q55260699 | Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics. |
| Q37704397 | Treatment of Acinetobacter infections |
| Q39922949 | Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system |
| Q39731315 | Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain |
| Q34995636 | Two methionine aminopeptidases from Acinetobacter baumannii are functional enzymes. |
Search more.